オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/17 | 1,770 | 1,820 | 1,739 | 1,780 | -13 | -0.7% | 235,400 |
2020/02/14 | 1,798 | 1,830 | 1,775 | 1,793 | -23 | -1.3% | 163,900 |
2020/02/13 | 1,831 | 1,858 | 1,802 | 1,816 | -23 | -1.3% | 123,100 |
2020/02/12 | 1,769 | 1,863 | 1,748 | 1,839 | +89 | +5.1% | 417,100 |
2020/02/10 | 1,754 | 1,777 | 1,748 | 1,750 | -54 | -3% | 142,900 |
2020/02/07 | 1,778 | 1,804 | 1,742 | 1,804 | +49 | +2.8% | 220,500 |
2020/02/06 | 1,740 | 1,762 | 1,736 | 1,755 | +18 | +1% | 157,200 |
2020/02/05 | 1,750 | 1,764 | 1,736 | 1,737 | -5 | -0.3% | 146,500 |
2020/02/04 | 1,750 | 1,779 | 1,736 | 1,742 | -4 | -0.2% | 174,500 |
2020/02/03 | 1,699 | 1,772 | 1,692 | 1,746 | -33 | -1.9% | 317,900 |
2020/01/31 | 1,751 | 1,790 | 1,730 | 1,779 | +15 | +0.9% | 333,000 |
2020/01/30 | 1,835 | 1,853 | 1,701 | 1,764 | -91 | -4.9% | 764,400 |
2020/01/29 | 1,940 | 1,961 | 1,850 | 1,855 | -95 | -4.9% | 497,400 |
2020/01/28 | 1,997 | 2,007 | 1,933 | 1,950 | -50 | -2.5% | 407,900 |
2020/01/27 | 1,935 | 2,049 | 1,922 | 2,000 | -12 | -0.6% | 1,291,100 |
2020/01/24 | 1,825 | 2,030 | 1,798 | 2,012 | +177 | +9.6% | 1,832,400 |
2020/01/23 | 1,854 | 1,863 | 1,827 | 1,835 | -38 | -2% | 224,900 |
2020/01/22 | 1,860 | 1,885 | 1,815 | 1,873 | +25 | +1.4% | 317,300 |
2020/01/21 | 1,800 | 1,928 | 1,799 | 1,848 | +33 | +1.8% | 645,800 |
2020/01/20 | 1,835 | 1,835 | 1,808 | 1,815 | -19 | -1% | 110,700 |
2020/01/17 | 1,813 | 1,840 | 1,801 | 1,834 | +15 | +0.8% | 217,100 |
2020/01/16 | 1,829 | 1,844 | 1,817 | 1,819 | -7 | -0.4% | 160,200 |
2020/01/15 | 1,850 | 1,858 | 1,825 | 1,826 | -41 | -2.2% | 194,700 |
2020/01/14 | 1,899 | 1,899 | 1,853 | 1,867 | -24 | -1.3% | 145,700 |
2020/01/10 | 1,841 | 1,904 | 1,834 | 1,891 | +41 | +2.2% | 279,700 |
2020/01/09 | 1,840 | 1,857 | 1,823 | 1,850 | +50 | +2.8% | 273,400 |
2020/01/08 | 1,900 | 1,904 | 1,772 | 1,800 | -110 | -5.8% | 1,002,700 |
2020/01/07 | 1,914 | 1,919 | 1,900 | 1,910 | +5 | +0.3% | 193,200 |
2020/01/06 | 1,904 | 1,918 | 1,900 | 1,905 | -18 | -0.9% | 223,000 |
2019/12/30 | 1,944 | 1,951 | 1,917 | 1,923 | -39 | -2% | 336,200 |
2019/12/27 | 1,941 | 1,962 | 1,929 | 1,962 | +21 | +1.1% | 553,600 |
2019/12/26 | 1,908 | 1,950 | 1,903 | 1,941 | +23 | +1.2% | 711,400 |
2019/12/25 | 1,930 | 1,932 | 1,910 | 1,918 | -1 | -0.1% | 321,200 |
2019/12/24 | 1,921 | 1,930 | 1,912 | 1,919 | -8 | -0.4% | 265,900 |
2019/12/23 | 1,940 | 1,942 | 1,920 | 1,927 | -18 | -0.9% | 265,500 |
2019/12/20 | 1,940 | 1,955 | 1,936 | 1,945 | -15 | -0.8% | 155,600 |
2019/12/19 | 1,936 | 1,961 | 1,932 | 1,960 | +22 | +1.1% | 186,000 |
2019/12/18 | 1,985 | 1,993 | 1,934 | 1,938 | -47 | -2.4% | 305,700 |
2019/12/17 | 1,921 | 1,985 | 1,913 | 1,985 | +63 | +3.3% | 484,900 |
2019/12/16 | 1,941 | 1,960 | 1,922 | 1,922 | -42 | -2.1% | 342,600 |
2019/12/13 | 1,990 | 2,050 | 1,956 | 1,964 | +37 | +1.9% | 1,395,400 |
2019/12/12 | 1,924 | 1,948 | 1,916 | 1,927 | +5 | +0.3% | 206,900 |
2019/12/11 | 1,923 | 1,925 | 1,912 | 1,922 | -1 | -0.1% | 126,700 |
2019/12/10 | 1,917 | 1,924 | 1,912 | 1,923 | ±0 | ±0% | 162,100 |
2019/12/09 | 1,934 | 1,940 | 1,919 | 1,923 | -11 | -0.6% | 132,100 |
2019/12/06 | 1,919 | 1,935 | 1,912 | 1,934 | +15 | +0.8% | 135,200 |
2019/12/05 | 1,940 | 1,940 | 1,903 | 1,919 | -8 | -0.4% | 283,100 |
2019/12/04 | 1,926 | 1,935 | 1,921 | 1,927 | -17 | -0.9% | 223,700 |
2019/12/03 | 1,931 | 1,946 | 1,925 | 1,944 | -1 | -0.1% | 402,600 |
2019/12/02 | 1,966 | 1,969 | 1,937 | 1,945 | -22 | -1.1% | 351,400 |
1351~
1400
件表示中 / 2861件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
扶桑薬 | 220,300円 | +1.6% | -12.7% | 4.09% | 8.18倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
市場注目の銘柄
チャート関連のコラム